Vera Therapeutics' Lead Kidney Drug Poised For 2026 Launch In Multi-Billion-Dollar Market

Vera Therapeutics' Lead Kidney Drug Poised For 2026 Launch In Multi-Billion-Dollar Market

Bank of America initiates coverage on Vera Therapeutics, citing strong potential for atacicept, its kidney treatment. Latest Ratings for VERA Date Firm Action From To Jun 2021 Evercore ISI Group Initiates Coverage On Outperform Jun 2021 Cowen & Co. Initiates Coverage On Outperform Jun 2021 Jefferies Initiates Coverage On Buy View More Analyst Ratings for VERA View the Latest Analyst Ratings read more